Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study.
Lisa A BeckDiamant ThaҫiMette DeleuranMarjolein de Bruin-WellerZhen ChenFaisal A KhokharMeng ZhangZafer E OzturkBrad ShumelPublished in: The Journal of dermatological treatment (2021)
NCT01949311.